NCT06115980 (XTR) is a NA clinical trial of lead extraction (Xtrac O.S. system) in Bradycardia, sponsored by Xtrac O.S..

Who is sponsoring NCT06115980?

NCT06115980 is sponsored by Xtrac O.S..

What drugs are being tested in NCT06115980?

Interventions in NCT06115980: lead extraction (Xtrac O.S. system).

What condition does NCT06115980 study?

NCT06115980 studies Bradycardia.

Is NCT06115980 still recruiting?

NCT06115980 is currently recruiting now. Last updated 13 August 2024.

Last reviewed 2024-08-13 · How we verify

NCT06115980: XTR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction.

Recruiting now NA Last updated 13 August 2024

What this trial tests

NA trial testing lead extraction (Xtrac O.S. system) in Bradycardia in 10 participants. Currently enrolling.

Timeline

27 August 2023

Primary endpoint
15 May 2025

20 July 2025

Quick facts

Lead sponsor	Xtrac O.S.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	27 August 2023
Primary completion	15 May 2025
Estimated completion	20 July 2025
Sites	1 location across Israel

Drugs / interventions tested

lead extraction (Xtrac O.S. system)

Conditions studied

Bradycardia — all drugs for Bradycardia →

Sponsor

Xtrac O.S.

Who can join

Adults 18 to 85, any sex, with Bradycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open label, interventional, feasibility, prospective, multicenter, clinical trial of lead extraction. The Xtrac O.S. system is intended for transvenous removal of pacing or defibrillator leads, having an inner lumen, through a superior approach. A total of 15 patients, who are scheduled for CIED lead extraction, will be recruited in order to ensure a total of at least 10 patients finishing the study procedures and follow up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bradycardia

Currently open trials in the same condition.

NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up · recruiting
NCT07254013 — Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution · NA · recruiting
NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
NCT07585799 — Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conductio · NA · recruiting
NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06115980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xtrac O.S.
Last refreshed: 13 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06115980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing